Your browser doesn't support javascript.
loading
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.
Infante, Jeffrey R; Cohen, Roger B; Kim, Kevin B; Burris, Howard A; Curt, Gregory; Emeribe, Ugochi; Clemett, Delyth; Tomkinson, Helen K; LoRusso, Patricia M.
Affiliation
  • Infante JR; Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK. jinfante@tnonc.com.
  • Cohen RB; Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA. jinfante@tnonc.com.
  • Kim KB; Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
  • Burris HA; California Pacific Medical Center (Sutterhealth), 475 Brannan Street, Suite 220, San Francisco, CA, 94107, USA.
  • Curt G; Sarah Cannon Research Institute, 93 Harley St, Marylebone, London, W1G 6AD, UK.
  • Emeribe U; Tennessee Oncology, PLLC, 250 25th Ave North, Nashville, TN, 37203, USA.
  • Clemett D; AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
  • Tomkinson HK; AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
  • LoRusso PM; AstraZeneca, Charter Way, Macclesfield, SK10 2NA, UK.
Invest New Drugs ; 35(5): 576-588, 2017 10.
Article in En | MEDLINE | ID: mdl-28424891
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2017 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2017 Type: Article Affiliation country: United kingdom